Betamethasone and vision loss: An alarming side effect!

Muhammad Wajeeh Anis, Mina Mansoor, Mohammad Ijlal Younus
{"title":"Betamethasone and vision loss: An alarming side effect!","authors":"Muhammad Wajeeh Anis, Mina Mansoor, Mohammad Ijlal Younus","doi":"10.47391/jpma.9815","DOIUrl":null,"url":null,"abstract":"Madam, Betamethasone is a potent steroid medication with immunosuppressive and anti-inflammatory properties, and it is frequently prescribed in Pakistan for conditions such as eczema, psoriasis and contact dermatitis due to its availability and affordability. However, it has significant adverse effects such as skin atrophy, striae and other cutaneous symptoms, and glaucoma.[1] Glaucoma is a severe condition characterized by pathologic elevation in intraocular pressure, leading to optic nerve damage and irreversible blindness. As highlighted by Sahni et al. topical steroid use in the periorbital area for an extended peri, for treating eczema can lead to detrimental visual problems and glaucoma [2]. In this case, a woman taking high dose topical steroids since the age of 16 started to develop frequent falls and blurring of vision. She had markedly elevated intraocular pressures and extensive peripheral visual field loss, consistent with advanced glaucoma. In addition to the study above Charles et al. also published a case report about a 43-year-old male who used betamethasone ointment on his body for eight months straight. Although he had precisely denied using the ointment near his eyes, he developed painless vision loss in his left eye due to glaucoma.[3] Additionally, a 2017 study highlighted a significant rise of vision impairment in Pakistan, an increase of 55% since 1990, with glaucoma prevalent in 0.14 million individuals, and eye diseases to further increase by 2025.[4] Consequently, this medication, which is being discontinued around the world, is still frequently used in Pakistan. Through this manuscript, I would like to bring this serious issue to light so that people in Pakistan can also be educated and protected from this serious side effect. Healthcare practitioners should strictly be avoiding this medication and using less harmful alternatives.","PeriodicalId":16673,"journal":{"name":"Journal of Pakistan Medical Association","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pakistan Medical Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47391/jpma.9815","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Madam, Betamethasone is a potent steroid medication with immunosuppressive and anti-inflammatory properties, and it is frequently prescribed in Pakistan for conditions such as eczema, psoriasis and contact dermatitis due to its availability and affordability. However, it has significant adverse effects such as skin atrophy, striae and other cutaneous symptoms, and glaucoma.[1] Glaucoma is a severe condition characterized by pathologic elevation in intraocular pressure, leading to optic nerve damage and irreversible blindness. As highlighted by Sahni et al. topical steroid use in the periorbital area for an extended peri, for treating eczema can lead to detrimental visual problems and glaucoma [2]. In this case, a woman taking high dose topical steroids since the age of 16 started to develop frequent falls and blurring of vision. She had markedly elevated intraocular pressures and extensive peripheral visual field loss, consistent with advanced glaucoma. In addition to the study above Charles et al. also published a case report about a 43-year-old male who used betamethasone ointment on his body for eight months straight. Although he had precisely denied using the ointment near his eyes, he developed painless vision loss in his left eye due to glaucoma.[3] Additionally, a 2017 study highlighted a significant rise of vision impairment in Pakistan, an increase of 55% since 1990, with glaucoma prevalent in 0.14 million individuals, and eye diseases to further increase by 2025.[4] Consequently, this medication, which is being discontinued around the world, is still frequently used in Pakistan. Through this manuscript, I would like to bring this serious issue to light so that people in Pakistan can also be educated and protected from this serious side effect. Healthcare practitioners should strictly be avoiding this medication and using less harmful alternatives.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
倍他米松和视力下降:一个惊人的副作用!
女士,倍他米松是一种有效的类固醇药物,具有免疫抑制和抗炎特性,在巴基斯坦,由于其可获得性和可负担性,它经常被用于湿疹、牛皮癣和接触性皮炎等病症。然而,它有明显的不良反应,如皮肤萎缩,条纹等皮肤症状,以及青光眼。[1]青光眼是一种以病理性眼压升高为特征的严重疾病,可导致视神经损伤和不可逆失明。正如Sahni等人所强调的那样,长期在眼眶周围区域局部使用类固醇治疗湿疹会导致有害的视力问题和青光眼[2]。在这个案例中,一名从16岁开始服用大剂量局部类固醇的女性开始出现频繁跌倒和视力模糊的情况。她有明显的眼压升高和广泛的周围视野丧失,符合晚期青光眼。除上述研究外,Charles等人还发表了一篇43岁男性连续8个月使用倍他米松软膏的病例报告。尽管他明确否认在眼睛附近使用这种药膏,但由于青光眼,他的左眼出现了无痛性视力丧失。[3]此外,2017年的一项研究强调,巴基斯坦的视力障碍显著增加,自1990年以来增加了55%,青光眼患病率为14万人,到2025年眼病将进一步增加。[4]因此,这种在世界各地都已停止使用的药物在巴基斯坦仍然经常使用。通过这篇手稿,我想把这个严重的问题曝光,以便巴基斯坦人民也能受到教育,并免受这种严重副作用的影响。医疗从业人员应严格避免使用这种药物,并使用危害较小的替代品。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Impact of haemodialysis on plasma carnitine concentrations in haemodialysis patients Surgical-orthodontic with atypical extraction pattern as a treatment for an anterior open bite: a case report Association between hip flexor tightness and lumbar instability in adults Utilization of the complete blood count in diagnosing endemic diseases in Pakistan Is a Therapeutic approach required to treat Insomnia in Pakistan?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1